CD4 and neoplasm: In addition, results revealed that the combination could significantly reduce the proportion of Tregs in CD4+ T cells (Figure S13A,B) and also increase the proportion of CD3+ T cells in splenic lymphocytes of tumor‐bearing mice (Figure S14A,B).